metastasis phenotype

Related entities (2)

Mentioned in (91)

Papers in which this entity is mentioned.

• A guide to transcriptomic deconvolution in cancer. (2026)
• Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types. (2026)
• Whole-genome landscapes of 1,364 breast cancers. (2026)
• Nanopore-based cell-free DNA fragmentation and methylation profiles from the cerebral spinal fluid of patients with lung cancer brain metastases. (2025)
• Rapid brain tumor classification from sparse epigenomic data. (2025)
• Chromosomal instability as a driver of cancer progression. (2025)
• High-Parameter Spatial Multi-Omics through Histology-Anchored Integration (2025)
• Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy. (2024)
• Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma. (2024)
• Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach. (2024)
• Synthetic augmentation of cancer cell line multi-omic datasets using unsupervised deep learning. (2024)
• Transient loss of Polycomb components induces an epigenetic cancer fate. (2024)
• ENPP1 Immunobiology as a Therapeutic Target. (2023)
• Osteoclasts in Osteosarcoma: Mechanisms, Interactions, and Therapeutic Prospects. (2023)
• Towards understandings of serine/arginine-rich splicing factors. (2023)
• RNA splicing dysregulation and the hallmarks of cancer. (2023)
• Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression. (2022)
• Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma. (2022)
• Integrated Genomic Analysis Identifies Driver Genes and Cisplatin-Resistant Progenitor Phenotype in Pediatric Liver Cancer. (2021)
• Accucopy: accurate and fast inference of allele-specific copy number alterations from low-coverage low-purity tumor sequencing data. (2021)
• A practical guide to cancer subclonal reconstruction from DNA sequencing. (2021)
• Therapeutic Implications of Germline Testing in Patients With Advanced Cancers. (2021)
• Integrative reconstruction of cancer genome karyotypes using InfoGenomeR. (2021)
• Choline Kinase: An Unexpected Journey for a Precision Medicine Strategy in Human Diseases. (2021)
• Biologically informed deep neural network for prostate cancer discovery. (2021)
• Macrophage Polarization States in the Tumor Microenvironment. (2021)
• Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. (2021)
• Immuno-genomic landscape of osteosarcoma. (2020)
• Pan-cancer analysis of whole genomes. (2020)
• Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. (2020)
• Ewing sarcoma with FEV gene rearrangements is a rare subset with predilection for extraskeletal locations and aggressive behavior. (2020)
• Emerging Roles of SRSF3 as a Therapeutic Target for Cancer. (2020)
• ABHD4-dependent developmental anoikis safeguards the embryonic brain. (2020)
• TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson's Disease. (2020)
• Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma. (2020)
• Accucopy: Accurate and Fast Inference of Allele-specific Copy Number Alterations from Low-coverage Low-purity Tumor Sequencing Data (2020)
• Neoadjuvant checkpoint blockade for cancer immunotherapy. (2020)
• Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. (2020)
• Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group. (2019)
• The mutational footprints of cancer therapies. (2019)
• The Clonal Evolution of Metastatic Osteosarcoma as Shaped by Cisplatin Treatment. (2019)
• Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients. (2019)
• Genome-Informed Targeted Therapy for Osteosarcoma. (2019)
• The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer. (2018)
• Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. (2018)
• Enter the Matrix: Factorization Uncovers Knowledge from Omics. (2018)
• Quantification of subclonal selection in cancer from bulk sequencing data. (2018)
• Comprehensive Characterization of Cancer Driver Genes and Mutations. (2018)
• Genome doubling shapes the evolution and prognosis of advanced cancers. (2018)
• Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. (2018)
• Sensitivity to sequencing depth in single-cell cancer genomics. (2018)
• ClonEvol: clonal ordering and visualization in cancer sequencing. (2017)
• Patient-derived xenografts undergo mouse-specific tumor evolution. (2017)
• Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. (2017)
• Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution. (2017)
• Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. (2017)
• Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype. (2017)
• B lymphocytes and cancer: a love-hate relationship. (2016)
• Statistical modeling for sensitive detection of low-frequency single nucleotide variants. (2016)
• Musculocontractural Ehlers-Danlos syndrome and neurocristopathies: dermatan sulfate is required for Xenopus neural crest cells to migrate and adhere to fibronectin. (2016)
• Inhibition of Mammary Cancer Progression in Fetal Alcohol Exposed Rats by β-Endorphin Neurons. (2016)
• Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. (2016)
• Development and clinical application of an integrative genomic approach to personalized cancer therapy. (2016)
• Prognostic value of inflammation-based scores in patients with osteosarcoma. (2016)
• A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis. (2015)
• The landscape of long noncoding RNAs in the human transcriptome. (2015)
• Comprehensive genomic profiles of small cell lung cancer. (2015)
• RADIA: RNA and DNA integrated analysis for somatic mutation detection. (2014)
• Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. (2014)
• Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. (2014)
• Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. (2014)
• Cancer genome landscapes. (2013)
• Large-scale genotyping identifies 41 new loci associated with breast cancer risk. (2013)
• A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. (2013)
• Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells. (2013)
• LIN28B promotes growth and tumorigenesis of the intestinal epithelium via Let-7. (2013)
• Myeloid cells in tumor inflammation. (2012)
• Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma. (2012)
• Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. (2012)
• Patient-derived tumour xenografts as models for oncology drug development. (2012)
• The Pediatric Cancer Genome Project. (2012)
• Functional consequences of developmentally regulated alternative splicing. (2011)
• "CRASH"ing with the worm: insights into L1CAM functions and mechanisms. (2010)
• The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. (2010)
• In vivo magnetic resonance spectroscopy: basic methodology and clinical applications. (2010)
• Cellular metabolic stress: considering how cells respond to nutrient excess. (2010)
• Adrenomedullin signaling is necessary for murine lymphatic vascular development. (2008)
• Role of platelet-derived growth factors in physiology and medicine. (2008)
• Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway. (2006)
• Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. (2005)
• Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. (2000)

Merged raw entities (1)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.